LY2603618: Selective Chk1 Inhibitor for Precision Cell Cy...
2025-10-21
LY2603618 is a highly selective checkpoint kinase 1 inhibitor that revolutionizes DNA damage response research by enabling precise G2/M cell cycle arrest and synergistic chemotherapy sensitization. Its ATP-competitive mechanism and robust activity in non-small cell lung cancer models set it apart for both mechanistic studies and translational oncology workflows.